301246 宏源药业
已收盘 02-11 15:00:00
资讯
新帖
简况
宏源药业:目前公司现有六氟磷酸钠产品设计产能400吨/年
证券之星 · 02-06
宏源药业:目前公司现有六氟磷酸钠产品设计产能400吨/年
股市必读:宏源药业(301246)2月4日董秘有最新回复
证券之星 · 02-05
股市必读:宏源药业(301246)2月4日董秘有最新回复
宏源药业:年产7000吨VC添加剂项目正处于建设中
证券之星 · 02-04
宏源药业:年产7000吨VC添加剂项目正处于建设中
宏源药业:六氟磷酸钠是钠电池的核心原材料
证券之星 · 02-03
宏源药业:六氟磷酸钠是钠电池的核心原材料
宏源药业(301246)披露关于变更签字注册会计师的公告,01月20日股价下跌3.87%
证券之星 · 01-20
宏源药业(301246)披露关于变更签字注册会计师的公告,01月20日股价下跌3.87%
股市必读:宏源药业(301246)预计2025年全年归属净利润盈利1.13亿元至1.37亿元
证券之星 · 01-19
股市必读:宏源药业(301246)预计2025年全年归属净利润盈利1.13亿元至1.37亿元
宏源药业(301246.SZ)发预增,预计2025年度归母净利润同比增长119.57%-166.20%
智通财经 · 01-16
宏源药业(301246.SZ)发预增,预计2025年度归母净利润同比增长119.57%-166.20%
宏源药业跌4.44% 2023年上市即巅峰超募15亿
中金财经 · 01-06
宏源药业跌4.44% 2023年上市即巅峰超募15亿
每周股票复盘:宏源药业(301246)因换手率上榜龙虎榜
证券之星 · 01-03
每周股票复盘:宏源药业(301246)因换手率上榜龙虎榜
12月29日宏源药业(301246)龙虎榜数据:游资章盟主上榜
证券之星 · 2025-12-29
12月29日宏源药业(301246)龙虎榜数据:游资章盟主上榜
宏源药业跌10.97% 2023年上市即巅峰超募15亿
中金财经 · 2025-12-29
宏源药业跌10.97% 2023年上市即巅峰超募15亿
12月26日宏源药业(301246)龙虎榜数据:游资章盟主上榜
证券之星 · 2025-12-26
12月26日宏源药业(301246)龙虎榜数据:游资章盟主上榜
异动快报:宏源药业(301246)12月26日10点33分触及涨停板
证券之星 · 2025-12-26
异动快报:宏源药业(301246)12月26日10点33分触及涨停板
股市必读:宏源药业(301246)12月25日董秘有最新回复
证券之星 · 2025-12-26
股市必读:宏源药业(301246)12月25日董秘有最新回复
宏源药业:已完成公斤级硫化物电解质样品制备
证券之星 · 2025-12-25
宏源药业:已完成公斤级硫化物电解质样品制备
宏源药业:六氟磷酸钠产销正常
证券之星 · 2025-12-23
宏源药业:六氟磷酸钠产销正常
宏源药业:已完成公斤级硫化物电解质样品制备
证券之星 · 2025-12-16
宏源药业:已完成公斤级硫化物电解质样品制备
宏源药业:已投产六氟磷酸锂产能10000吨/年
证券之星 · 2025-12-11
宏源药业:已投产六氟磷酸锂产能10000吨/年
宏源药业(301246)披露2025年持续督导定期现场检查报告,12月09日股价下跌1.41%
证券之星 · 2025-12-09
宏源药业(301246)披露2025年持续督导定期现场检查报告,12月09日股价下跌1.41%
宏源药业:积极探索优质中药处方转化与开发
证券之星 · 2025-12-09
宏源药业:积极探索优质中药处方转化与开发
加载更多
公司概况
公司名称:
湖北省宏源药业科技股份有限公司
所属行业:
医药制造业
上市日期:
2023-03-20
主营业务:
湖北省宏源药业科技股份有限公司的主营业务是有机化学原料、医药中间体、原料药及医药制剂研发、生产和销售。公司的主要产品是乙二醛、乙醛酸、2-甲基-5-硝基咪唑、甲硝唑、鸟嘌呤及六氟磷酸锂等。
发行价格:
50.00
{"stockData":{"symbol":"301246","market":"SZ","secType":"STK","nameCN":"宏源药业","latestPrice":21.78,"timestamp":1770793392000,"preClose":21.43,"halted":0,"volume":7762094,"delay":0,"changeRate":0.0163,"floatShares":160000000,"shares":400000000,"eps":0.0356,"marketStatus":"已收盘","change":0.35,"latestTime":"02-11 15:00:00","open":21.44,"high":22.05,"low":21.37,"amount":169000000,"amplitude":0.0317,"askPrice":21.79,"askSize":157,"bidPrice":21.78,"bidSize":401,"shortable":0,"etf":0,"ttmEps":0.0356,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770859800000},"marketStatusCode":5,"adr":0,"adjPreClose":21.43,"symbolType":"stock","openAndCloseTimeList":[[1770773400000,1770780600000],[1770786000000,1770793200000]],"highLimit":23.57,"lowLimit":19.29,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":400006800,"isCdr":false,"pbRate":1.98,"roa":"--","peRate":611.797753,"roe":"--","epsLYR":0.1291,"committee":0.017078,"marketValue":8712000000,"turnoverRate":0.0485,"status":0,"floatMarketCap":3486000000},"requestUrl":"/m/hq/s/301246","defaultTab":"news","newsList":[{"id":"2609030536","title":"宏源药业:目前公司现有六氟磷酸钠产品设计产能400吨/年","url":"https://stock-news.laohu8.com/highlight/detail?id=2609030536","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609030536?lang=zh_cn&edition=full","pubTime":"2026-02-06 08:39","pubTimestamp":1770338350,"startTime":"0","endTime":"0","summary":"证券之星消息,宏源药业(301246)02月05日在投资者关系平台上答复投资者关心的问题。投资者提问:六氟磷酸钠的产能有多少,开工率是多少?宏源药业回复:您好,目前公司现有六氟磷酸钠产品设计产能400吨/年,产能利用率情况请关注公司后续定期报告。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600007490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2609394360","title":"股市必读:宏源药业(301246)2月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2609394360","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609394360?lang=zh_cn&edition=full","pubTime":"2026-02-05 01:41","pubTimestamp":1770226870,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘,宏源药业报收于21.31元,上涨0.38%,换手率2.98%,成交量4.77万手,成交额1.01亿元。董秘最新回复投资者: 董秘你好,请问7000吨VC啥时候投产?VC,LIFSI等其他添加剂看起来更有上涨空间,请公司重视,未雨绸缪!董秘: 您好,公司年产7000吨VC添加剂项目正处于建设中,预计在2026年四季度可以投产,目前还没规划LIFSI等其他添加剂。当日关注点来自交易信息汇总:2月4日主力资金净流出700.68万元,散户资金净流入485.64万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500001002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2608135954","title":"宏源药业:年产7000吨VC添加剂项目正处于建设中","url":"https://stock-news.laohu8.com/highlight/detail?id=2608135954","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608135954?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:39","pubTimestamp":1770194346,"startTime":"0","endTime":"0","summary":"证券之星消息,宏源药业02月04日在投资者关系平台上答复投资者关心的问题。VC,LIFSI等其他添加剂看起来更有上涨空间,请公司重视,未雨绸缪!宏源药业回复:您好,公司年产7000吨VC添加剂项目正处于建设中,预计在2026年四季度可以投产,目前还没规划LIFSI等其他添加剂。关于医药行业,公司已建立了较为完善的医药产业链,产品销往全球几十个国家和地区,与国内外知名制药企业建立了良好的合作关系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400027444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2608814483","title":"宏源药业:六氟磷酸钠是钠电池的核心原材料","url":"https://stock-news.laohu8.com/highlight/detail?id=2608814483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608814483?lang=zh_cn&edition=full","pubTime":"2026-02-03 08:51","pubTimestamp":1770079869,"startTime":"0","endTime":"0","summary":"证券之星消息,宏源药业(301246)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司打算提升六氟磷酸钠产能吗?如何看待未来3-5年钠电池的市场发展?宏源药业回复:您好,六氟磷酸钠是钠电池的核心原材料,随着六氟磷酸锂市场的好转,六氟磷酸钠价格优势凸显,未来将会根据六氟磷酸钠的市场行情变化进行规划,具体情况请关注公司的相关信息披露。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300007496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159796","301246"],"gpt_icon":0},{"id":"2604111883","title":"宏源药业(301246)披露关于变更签字注册会计师的公告,01月20日股价下跌3.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111883","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604111883?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:12","pubTimestamp":1768918344,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘,宏源药业报收于21.83元,较前一交易日下跌3.87%,最新总市值为87.32亿元。公司于近日发布公告称,因中审众环会计师事务所内部工作调整,将公司2025年度财务报告及内部控制审计的签字注册会计师由原李维、彭冬梅变更为李维、方梦苑。方梦苑自2014年起从事上市公司审计,2012年起在中审众环执业,2025年开始为公司提供审计服务,近三年无签署上市公司审计报告记录,未受过监管处罚,符合独立性要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000039485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2604974922","title":"股市必读:宏源药业(301246)预计2025年全年归属净利润盈利1.13亿元至1.37亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604974922","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604974922?lang=zh_cn&edition=full","pubTime":"2026-01-19 03:11","pubTimestamp":1768763467,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘,宏源药业报收于22.57元,上涨1.17%,换手率9.58%,成交量15.33万手,成交额3.44亿元。业绩披露要点业绩预告宏源药业发布业绩预告,预计2025年全年归属净利润盈利1.13亿元至1.37亿元;扣非后净利润预计盈利8200万元至1.06亿元。公司公告汇总2025年度业绩预告湖北省宏源药业科技股份有限公司预计2025年度归属于上市公司股东的净利润为11,300万元至13,700万元,同比增长119.57%至166.20%;扣除非经常性损益后的净利润为8,200万元至10,600万元,同比增长782.01%至1,040.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900001155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246"],"gpt_icon":0},{"id":"2603396762","title":"宏源药业(301246.SZ)发预增,预计2025年度归母净利润同比增长119.57%-166.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603396762","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603396762?lang=zh_cn&edition=full","pubTime":"2026-01-16 18:56","pubTimestamp":1768561017,"startTime":"0","endTime":"0","summary":"智通财经APP讯,宏源药业(301246.SZ)发布2025年度业绩预告,预计全年实现归属于上市公司股东的净利润1.13亿元至1.37亿元,同比增长119.57%-166.20%。2025年度经营业绩预计较去年同期大幅上升,主要受六氟磷酸锂业务影响。报告期内,新能源车市场需求持续增长以及储能市场需求快速增长,公司六氟磷酸锂业务盈利能力显著改善。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"宏源药业(301246.SZ)发预增,预计2025年度归母净利润同比增长119.57%-166.20%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301246"],"gpt_icon":0},{"id":"2601898414","title":"宏源药业跌4.44% 2023年上市即巅峰超募15亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2601898414","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601898414?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:29","pubTimestamp":1767691752,"startTime":"0","endTime":"0","summary":"中国经济网北京1月6日讯 宏源药业 今日收报24.11元,跌幅4.44%。该股目前处于破发状态。 宏源药业于2023年3月20日在深交所创业板上市,公开发行股票4,725.72万股,发行价格为50.00元/股,保荐机构为民生证券股份有限公司,保荐代表人为谢广化、肖继明。 宏源药业首次公开发行股票募集资金总额为人民币236,286.00万元,扣除发行费用后募集资金净额为219,584.37万元。 宏源药业首次公开发行股票的发行费用总额为16,701.63万元,其中保荐及承销费用13,931.96万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260106/31919552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2600629480","title":"每周股票复盘:宏源药业(301246)因换手率上榜龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2600629480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600629480?lang=zh_cn&edition=full","pubTime":"2026-01-03 02:03","pubTimestamp":1767376991,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,宏源药业报收于25.0元,较上周的26.88元下跌6.99%。本周,宏源药业12月29日盘中最高价报26.5元。12月30日盘中最低价报22.05元。宏源药业当前最新总市值100.0亿元,在化学制药板块市值排名55/150,在两市A股市值排名1916/5181。本周关注点交易信息汇总:宏源药业因日换手率达30%登上龙虎榜,近5个交易日内第2次上榜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300000343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2595866647","title":"12月29日宏源药业(301246)龙虎榜数据:游资章盟主上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2595866647","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595866647?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:38","pubTimestamp":1767001131,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年12月29日公布的交易公开信息显示,宏源药业因日换手率达到30%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年12月29日收盘,宏源药业报收于23.93元,下跌10.97%,换手率37.37%,成交量59.81万手,成交额14.42亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出1331.98万元,北向资金合计净买入4302.43万元。章盟主等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900023827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2595028783","title":"宏源药业跌10.97% 2023年上市即巅峰超募15亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2595028783","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595028783?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:59","pubTimestamp":1766998762,"startTime":"0","endTime":"0","summary":"中国经济网北京12月29日讯 宏源药业 今日收报23.93元,跌幅10.97%。该股目前处于破发状态。 宏源药业于2023年3月20日在深交所创业板上市,公开发行股票4,725.72万股,发行价格为50.00元/股,保荐机构为民生证券股份有限公司,保荐代表人为谢广化、肖继明。 宏源药业首次公开发行股票募集资金总额为人民币236,286.00万元,扣除发行费用后募集资金净额为219,584.37万元。 宏源药业首次公开发行股票的发行费用总额为16,701.63万元,其中保荐及承销费用13,931.96万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20251229/31899727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2594260061","title":"12月26日宏源药业(301246)龙虎榜数据:游资章盟主上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2594260061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594260061?lang=zh_cn&edition=full","pubTime":"2025-12-26 17:47","pubTimestamp":1766742473,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年12月26日公布的交易公开信息显示,宏源药业因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年12月26日收盘,宏源药业报收于26.88元,上涨20.0%,涨停,换手率29.79%,成交量47.68万手,成交额12.16亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入2773.34万元。章盟主等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600025913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2594682662","title":"异动快报:宏源药业(301246)12月26日10点33分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2594682662","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594682662?lang=zh_cn&edition=full","pubTime":"2025-12-26 10:35","pubTimestamp":1766716528,"startTime":"0","endTime":"0","summary":"证券之星12月26日盘中消息,10点33分宏源药业触及涨停板。其所属行业化学制药目前下跌。该股为锂电池,固态电池,新能源汽车概念热股,当日锂电池概念上涨1.31%,固态电池概念上涨1.11%,新能源汽车概念上涨0.45%。12月25日的资金流向数据方面,主力资金净流入1321.5万元,占总成交额1.6%,游资资金净流出932.48万元,占总成交额1.13%,散户资金净流出389.02万元,占总成交额0.47%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600009159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2594253218","title":"股市必读:宏源药业(301246)12月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2594253218","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594253218?lang=zh_cn&edition=full","pubTime":"2025-12-26 02:07","pubTimestamp":1766686034,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘,宏源药业报收于22.4元,上涨7.74%,换手率24.52%,成交量39.25万手,成交额8.25亿元。董秘最新回复投资者: 四季度六氟磷酸锂价格大涨,肯定会带动公司业绩大幅增长,请问一月份会不会发布业绩预告,大概什么时间发布?董秘: 您好,若公司2025年度经营业绩符合业绩预告披露要求,公司将按照相关规定,在本会计年度结束之日起一个月内进行业绩预告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600000691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2594235367","title":"宏源药业:已完成公斤级硫化物电解质样品制备","url":"https://stock-news.laohu8.com/highlight/detail?id=2594235367","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594235367?lang=zh_cn&edition=full","pubTime":"2025-12-25 17:00","pubTimestamp":1766653247,"startTime":"0","endTime":"0","summary":"证券之星消息,宏源药业12月25日在投资者关系平台上答复投资者关心的问题。另外,固态硫化物电解质目前的工艺优化进展是否有明确的阶段性节点?谢谢公司的互动和交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500024867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2593549832","title":"宏源药业:六氟磷酸钠产销正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2593549832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593549832?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:25","pubTimestamp":1766478328,"startTime":"0","endTime":"0","summary":"证券之星消息,宏源药业12月23日在投资者关系平台上答复投资者关心的问题。公司如何看待六氟磷酸钠今后几年的发展,有计划2026年扩产吗?六氟磷酸钠是钠电池的核心原材料,随着六氟磷酸锂市场的好转,六氟磷酸钠价格优势凸显,未来将更有利于六氟磷酸钠的市场规模扩大。我司现有设计产能400吨/年,后期一旦市场需求发生较大增长,我司会适时调整增加产能。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300023045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2591115675","title":"宏源药业:已完成公斤级硫化物电解质样品制备","url":"https://stock-news.laohu8.com/highlight/detail?id=2591115675","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591115675?lang=zh_cn&edition=full","pubTime":"2025-12-16 08:54","pubTimestamp":1765846453,"startTime":"0","endTime":"0","summary":"证券之星消息,宏源药业(301246)12月15日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司的硫化物固态电解质公斤级性能已达标后,中试计划何时提上日程?该技术是和武汉大学还是黄冈师范一起研制的吗,还是公司独立研发?宏源药业回复:您好,目前公司已完成公斤级硫化物电解质前驱体及电解质样品制备,就固态电解质进行测试优化,目前正在筹备中试线建设工作,该项目是与黄冈师范学院共同研发。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600006050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0},{"id":"2590595242","title":"宏源药业:已投产六氟磷酸锂产能10000吨/年","url":"https://stock-news.laohu8.com/highlight/detail?id=2590595242","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590595242?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:34","pubTimestamp":1765442048,"startTime":"0","endTime":"0","summary":"关于六氟磷酸锂自有产能:当前自有投产产能8000吨/年;罗田6000吨/年高纯晶体六氟磷酸锂改扩建项目正建设中;武穴锂电一体化项目一期规划12000吨/年六氟磷酸锂产能参股公司湖北中蓝宏源拥有4000吨/年的六氟磷酸锂产能。宏源药业回复:您好,目前公司已投产装置能力10000吨/年,罗田6000吨/年高纯晶体六氟磷酸锂改扩建项目正建设中;湖北中蓝宏源新能源材料有限公司已投产装置能力6000吨/年。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100024122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2590344234","title":"宏源药业(301246)披露2025年持续督导定期现场检查报告,12月09日股价下跌1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590344234","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590344234?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:11","pubTimestamp":1765289484,"startTime":"0","endTime":"0","summary":"截至2025年12月9日收盘,宏源药业报收于17.43元,较前一交易日下跌1.41%,最新总市值为69.72亿元。该股当日开盘17.67元,最高17.7元,最低17.4元,成交额达7896.2万元,换手率为2.82%。近日,国联民生证券承销保荐有限公司发布了《关于湖北省宏源药业科技股份有限公司2025年持续督导定期现场检查报告》。公告显示,国联民生证券于2025年11月26日至11月28日对宏源药业进行了2025年度持续督导的现场检查。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900040275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301246","BK0239"],"gpt_icon":0},{"id":"2590367120","title":"宏源药业:积极探索优质中药处方转化与开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2590367120","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590367120?lang=zh_cn&edition=full","pubTime":"2025-12-09 08:42","pubTimestamp":1765240933,"startTime":"0","endTime":"0","summary":"证券之星消息,宏源药业(301246)12月08日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,我是一名具有多年临床经验的中医,手里有一些临床疗效很好的处方,贵公司虽然也有中成药业务,但并不是独家品牌,那么请问咱们是否可以合作,把这些处方开发出来呢?宏源药业回复:您好,感谢您带来优质临床处方资源,公司欢迎此类合作机会,积极探索优质中药处方的转化与开发,助力业务升级与独家品种拓展。谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900004671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301246"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770807785887,"stockEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":-0.0303},{"period":"3month","weight":0.0047},{"period":"6month","weight":0.3934},{"period":"1year","weight":0.548},{"period":"ytd","weight":-0.1428}],"compareEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":0.0019},{"period":"3month","weight":0.0321},{"period":"6month","weight":0.126},{"period":"1year","weight":0.2427},{"period":"ytd","weight":0.0402}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖北省宏源药业科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"28012人(较上一季度减少9.76%)","perCapita":"5713股","listingDate":"2023-03-20","address":"湖北省黄冈市罗田县凤山镇经济开发区宏源路8号","registeredCapital":"40000万元","survey":" 湖北省宏源药业科技股份有限公司的主营业务是有机化学原料、医药中间体、原料药及医药制剂研发、生产和销售。公司的主要产品是乙二醛、乙醛酸、2-甲基-5-硝基咪唑、甲硝唑、鸟嘌呤及六氟磷酸锂等。","listedPrice":50},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"宏源药业(301246)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供宏源药业(301246)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"宏源药业,301246,宏源药业股票,宏源药业股票老虎,宏源药业股票老虎国际,宏源药业行情,宏源药业股票行情,宏源药业股价,宏源药业股市,宏源药业股票价格,宏源药业股票交易,宏源药业股票购买,宏源药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"宏源药业(301246)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供宏源药业(301246)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}